Somerville, MA, United States of America

Angelika Fretzen

This inventor holds 21 USPTO granted patents and 43 published patent applications, plus 7 CIPO patents and 13 EPO patents, primarily in Gastrointestinal Treatments. Top assignees: Ironwood Pharmaceuticals, Inc., Forest Laboratories Holdings Limited, Ironwood Pharmaceutical, Inc.. Active years: 2008-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Angelika Fretzen. Retrieved from https://idiyas.com/inventor/angelika-fretzen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 43)

% Patents Active = 76.2

CIPO Patents = 7 (Patent Applications = 5)

EPO Patents = 13 (Patent Applications = 19)

Average Co-Inventor Count = 5.1

ph-index = 7

Forward Citations = 146(Granted Patents)

Company Filing History:

18 out of 44

Ironwood Pharmaceuticals, Inc.

patents

3 out of 26

Forest Laboratories Holdings Limited

patents

1 out of 1

Ironwood Pharmaceutical, Inc.

patent

4. 1 out of 1

Ironwwod Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2008-2020

Loading Chart...

Areas of Expertise:

Linaclotide

Stable Formulations

sGC Stimulators

Gastrointestinal Disorders

FAAH Inhibitors

Heart Failure Treatments

GC-C Receptor Agonist

Oral Administration

Compositions

Polypeptide

2-Benzyl Pyrazoles

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10702576 - Stable formulations of linaclotide (2020-07-07),

2. 10675325 - Stable formulations of linaclotide (2020-06-09),

3. 10189809 - SGC stimulators (2019-01-29),

4. 9708371 - Treatments for gastrointestinal disorders (2017-07-18),

5. 9657012 - FAAH inhibitors (2017-05-23),

6. 9650417 - Treatments for gastrointestinal disorders (2017-05-16),

7. 9617305 - Treatments for gastrointestinal disorders (2017-04-11),

8. 9527887 - Treatments for gastrointestinal disorders (2016-12-27),

9. 9309235 - SGC stimulators (2016-04-12),

10. 9139564 - 2-benzyl, 3-(pyrimidin-2-yl) substituted pyrazoles useful as sGC stimulators (2015-09-22),

11. 8946158 - Treatments of gastrointestinal disorders (2015-02-03),

12. 8933030 - Treatments for gastrointestinal disorders (2015-01-13),

13. 8802628 - Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration (2014-08-12),

14. 8779090 - Methods and compositions for the treatment of heart failure and other disorders (2014-07-15),

15. 8748573 - Formulations comprising linaclotide (2014-06-10),

Title: Inventor Angelika Fretzen - Revolutionizing Technology in Somerville

Introduction: Angelika Fretzen is a pioneering inventor based in Somerville, MA, known for her groundbreaking contributions to the field of technology.

Latest Patents: Angelika Fretzen holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing her diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Angelika Fretzen has worked with top research institutions and leading tech companies, consistently pushing the boundaries of technological advancements.

Collaborations: Throughout her career, Angelika Fretzen has collaborated with renowned scientists, engineers, and inventors, fostering a culture of innovation and creativity in her projects.

Conclusion: Angelika Fretzen's passion for innovation and her relentless pursuit of technological excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.